Literature DB >> 8807580

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy.

S J Shankland1, J Pippin, R H Pichler, K L Gordon, S Friedman, L I Gold, R J Johnson, W G Couser.   

Abstract

In membranous nephropathy (MN) overproduction of matrix by glomerular epithelial cells (GEC) is believed to be responsible for glomerular basement membrane thickening and spikes. We studied experimental MN in rats (passive Heymann nephritis, PHN) at 5, 10 and 30 days. PHN rats exhibited a marked increase in GEC immunostaining for TGF-beta 2 at all time points. TGF-beta 3 staining was increased at day 10 only, and TGF-beta 1 was unchanged. Glomerular mRNA for TGF-beta 2 and -beta 3 was increased by day 5 when urine protein increased, whereas TGF-beta 1 was not. TGF-beta 2 bioactivity was increased at day 5. There was also a marked increase in GEC immunostaining for TGF-beta receptor type I (T beta IR) and TGF-beta receptor type II (T beta IIR) at all time points in PHN. mRNA levels for both receptors increased at day 5. Increases in protein expression and mRNA levels for the TGF-beta 2 and -beta 3 isoforms, and T beta IR and T beta RII were prevented by complement depletion. We conclude that complement-mediated injury to the GEC in vivo is associated with the up-regulation of TGF-beta 2 and -beta 3 isoforms, an increase in TGF-beta 2 bioactivity, and an increase in T beta RI and T beta RII expression. This contrasts with changes in TGF-beta 1 reported in mesangial disease, suggesting that TGF-beta 2 and -beta 3 may be important in diseases of the GEC. The differential expression of TGF-beta isoforms and receptors may be important determinants of the GEC response to injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807580     DOI: 10.1038/ki.1996.294

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells.

Authors:  Jeong-Hyeon Sohn; Puran S Bora; Hye-Jung Suk; Hector Molina; Henry J Kaplan; Nalini S Bora
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

Review 2.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

3.  Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Authors:  Janina Müller-Deile; Jan Dannenberg; Patricia Schroder; Meei-Hua Lin; Jeffrey H Miner; Rongjun Chen; Jan-Hinrich Bräsen; Thomas Thum; Jenny Nyström; Lynne Beverly Staggs; Hermann Haller; Jan Fiedler; Johan M Lorenzen; Mario Schiffer
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

4.  Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.

Authors:  P K Datta; R S Reddy; E A Lianos
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

5.  Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.

Authors:  Tian-tian Li; Xiao-hui Zhang; Jing-feng Jing; Xin Li; Xiao-qian Yang; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

6.  Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy.

Authors:  Peter V Hauser; Paul Perco; Irmgard Mühlberger; Jeffrey Pippin; Mary Blonski; Bernd Mayer; Charles E Alpers; Rainer Oberbauer; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2009-04-18

7.  Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.

Authors:  Andrea Hartner; Karl F Hilgers; Markus Bitzer; Roland Veelken; Harald O Schöcklmann
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

8.  SPARC accelerates disease progression in experimental crescentic glomerulonephritis.

Authors:  Amy N Sussman; Tong Sun; Ronald M Krofft; Raghu V Durvasula
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

9.  Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.

Authors:  Ilse Daehn; Gabriella Casalena; Taoran Zhang; Shaolin Shi; Franz Fenninger; Nicholas Barasch; Liping Yu; Vivette D'Agati; Detlef Schlondorff; Wilhelm Kriz; Borje Haraldsson; Erwin P Bottinger
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

10.  DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.

Authors:  Jeffrey W Pippin; Raghu Durvasula; Arndt Petermann; Keiju Hiromura; William G Couser; Stuart J Shankland
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.